Antiparkinson Agents (administration & dosage) < Antiparkinson Agents (adverse effects) < Antiparkinson Agents (antagonists & inhibitors)

Facettes :

List of bibliographic references indexed by Antiparkinson Agents (adverse effects)

Number of relevant bibliographic references: 373.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000192 (2015)	C Warren Olanow [États-Unis]	Levodopa: effect on cell death and the natural history of Parkinson's disease.
000294 (2015)	Camila Catherine Aquino [Canada] ; Susan H. Fox	Clinical spectrum of levodopa-induced complications.
000309 (2015)	Isabelle Beaulieu-Boire [Canada] ; Anthony E. Lang	Behavioral effects of levodopa.
000390 (2014)	Erwan Bezard [République populaire de Chine] ; Elsa Y. Pioli ; Qin Li ; Françoise Girard ; Vincent Mutel ; Charlotte Keywood ; Francois Tison ; Olivier Rascol ; Sonia M. Poli	The mGluR5 negative allosteric modulator dipraglurant reduces dyskinesia in the MPTP macaque model.
000407 (2014)	Barbara Picconi [Italie] ; Paolo Calabresi	Targeting metabotropic glutamate receptors as a new strategy against levodopa-induced dyskinesia in Parkinson's disease?
000544 (2014)	C Warren Olanow [États-Unis] ; Karl Kieburtz ; Fabrizio Stocchi	Initiating levodopa therapy for Parkinson's disease.
000570 (2014)	Pantelis Stathis [Grèce] ; Vasilios Tzias ; Pavlos Argyris ; Georgia Barla ; Maria Maltezou	Gastric bezoar complication of Duodopa(®) therapy in Parkinson's disease, treated with Coca-Cola(®).
000598 (2014)	Peter A. Lewitt [États-Unis] ; F Jacob Huff ; Robert A. Hauser ; Dan Chen ; Dmitri Lissin ; Katie Zomorodi ; Kenneth C. Cundy	Double-blind study of the actively transported levodopa prodrug XP21279 in Parkinson's disease.
000628 (2014)	Wai Kin D. Ko [France] ; Elsa Pioli ; Qin Li ; Steve Mcguire ; Audrey Dufour ; Todd B. Sherer ; Erwan Bezard ; Maurizio F. Facheris	Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease.
000658 (2014)	Shraddha Sapkota [Canada] ; Myrlene Gee ; Jennifer Sabino ; Derek Emery ; Richard Camicioli	Association of homocysteine with ventricular dilatation and brain atrophy in Parkinson's disease.
000678 (2014)	Danhui Zhang [États-Unis] ; Tanuja Bordia [États-Unis] ; Matthew Mcgregor [États-Unis] ; J. Michael Mcintosh [États-Unis] ; Michael W. Decker [États-Unis] ; Maryka Quik [États-Unis]	ABT-089 and ABT-894 Reduce L-Dopa-Induced Dyskinesias in a Monkey Model of Parkinson’s Disease
000699 (2013)	Christopher G. Goetz [États-Unis] ; Glenn T. Stebbins ; Kathryn A. Chung ; Robert A. Hauser ; Janis M. Miyasaki ; Anthony P. Nicholas ; Werner Poewe [Autriche] ; Klaus Seppi ; Olivier Rascol ; Mark A. Stacy ; John G. Nutt ; Caroline M. Tanner ; Alison Urkowitz ; Jean A. Jaglin ; Song Ge	Which dyskinesia scale best detects treatment response?
000702 (2013)	Patrícia Pita Lobo ; Miguel Coelho ; Tiago A. Mestre ; Mário M. Rosa ; Joaquim J. Ferreira	Wearing-off phenomena and levodopa-induced dyskinesias in posttraumatic hemiparkinsonism.
000719 (2013)	Yoshikuni Mizuno [Japon] ; Masahiro Nomoto ; Tomoyoshi Kondo ; Kazuko Hasegawa ; Miho Murata ; Masahiro Takeuchi ; Junji Ikeda ; Takayuki Tomida ; Nobutaka Hattori	Transdermal rotigotine in early stage Parkinson's disease: a randomized, double-blind, placebo-controlled trial.
000779 (2013)	Michael S. Okun ; Daniel Weintraub	Should Impulse Control Disorders and Dopamine Dysregulation Syndrome be Indications for Deep Brain Stimulation and Intestinal Levodopa?
000788 (2013)	Amit Batla [Royaume-Uni] ; Maria Stamelou [Royaume-Uni] ; Niccolo Mencacci [Royaume-Uni, Italie] ; Anthony H. Schapira [Royaume-Uni] ; Kailash P. Bhatia [Royaume-Uni]	Ropinirole monotherapy induced severe reversible dyskinesias in Parkinson’s disease
000810 (2013)	Onanong Jitkritsadakul ; Priya Jagota ; Sitthi Petchrutchatachart ; Lalana Sansopha ; Rungsun Rerknimitr ; Roongroj Bhidayasiri	Recurrent pancreatitis as a rare complication of duodenal levodopa infusion treatment.
000861 (2013)	Alex A. Macdonald [Canada] ; Oury Monchi ; Ken N. Seergobin ; Hooman Ganjavi ; Ruzbeh Tamjeedi ; Penny A. Macdonald	Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function.
000890 (2013)	Roberto Ceravolo [Italie] ; Giovanni Cossu ; Monica Bandettini Di Poggio ; Lucio Santoro ; Paolo Barone ; Maurizio Zibetti ; Daniela Frosini ; Valentina Nicoletti ; Fiore Manganelli ; Rosa Iodice ; Marina Picillo ; Aristide Merola ; Leonardo Lopiano ; Alessandra Paribello ; Davide Manca ; Maurizio Melis ; Roberta Marchese ; Paolo Borelli ; Alessandra Mereu ; Paolo Contu ; Giovanni Abbruzzese ; Ubaldo Bonuccelli	Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study.
000897 (2013)	Daniel J. Burdick [États-Unis] ; Alida Griffith ; Pinky Agarwal	Mydriasis in a Parkinson disease patient on low-dose carbidopa/levodopa.
000935 (2013)	Mun Kyung Sunwoo ; Kyung Min Kim ; Jin Yong Hong ; Young H. Sohn ; Phil Hyu Lee	Levodopa-induced dyskinesia in a patient who has normal presynaptic dopaminergic neurons.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Antiparkinson Agents (adverse effects)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Antiparkinson Agents (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antiparkinson Agents (adverse effects)
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024